Insider Buying: Oxford Nanopore Technologies plc (LON:ONT) Insider Acquires 53 Shares of Stock – MarketBeat

Sign up for MarketBeat All Access to gain access to MarketBeat’s full suite of research tools:
Oxford Nanopore Technologies plc (LON:ONT – Get Rating) insider Clive Brown bought 53 shares of the firm’s stock in a transaction dated Tuesday, September 13th. The stock was purchased at an average price of GBX 288 ($3.48) per share, for a total transaction of £152.64 ($184.44).
Clive Brown also recently made the following trade(s):

• On Tuesday, July 12th, Clive Brown bought 46 shares of Oxford Nanopore Technologies stock. The stock was purchased at an average price of GBX 323 ($3.90) per share, for a total transaction of £148.58 ($179.53).

Oxford Nanopore Technologies Stock Performance

ONT stock traded up GBX 11.50 ($0.14) on Tuesday, reaching GBX 283.50 ($3.43). The company had a trading volume of 1,269,495 shares, compared to its average volume of 1,385,703. Oxford Nanopore Technologies plc has a 1 year low of GBX 239 ($2.89) and a 1 year high of GBX 736 ($8.89). The company has a market capitalization of £2.34 billion and a P/E ratio of -12.31. The firm’s fifty day moving average price is GBX 298.84. The company has a current ratio of 7.15, a quick ratio of 5.23 and a debt-to-equity ratio of 3.52.

Analyst Upgrades and Downgrades

Several equities analysts have recently weighed in on ONT shares. Barclays decreased their target price on Oxford Nanopore Technologies from GBX 700 ($8.46) to GBX 500 ($6.04) and set an “overweight” rating on the stock in a research report on Tuesday, May 31st. Berenberg Bank restated a “buy” rating and issued a GBX 671 ($8.11) target price on shares of Oxford Nanopore Technologies in a research report on Monday, August 8th. Finally, Royal Bank of Canada reaffirmed an “outperform” rating and issued a GBX 400 ($4.83) price target on shares of Oxford Nanopore Technologies in a report on Monday, August 8th.

Oxford Nanopore Technologies Company Profile

(Get Rating)
Oxford Nanopore Technologies plc develops and commercializes a technology platform using nanopore-based sensing for the analysis of various types of molecules. The company offers MinION, a portable device for deoxyribonucleic acid and ribonucleic acid sequencing; GridION, a self-contained benchtop device for running and analyzing up to five MinION or Flongle flow cells; MinION Mk1C for basecalling and data analysis, touchscreen operation, and wireless connectivity; Flongle, an adapter for use in MinION or GridION devices to attach a Flongle flow cell; GridION Mk1, a benchtop nanopore sequencer; PromethION 2 Solo and PromethION 2, a low-cost access to high-yield PromethION sequencing; PromethION 24 and PromethION 48 benchtop nanopore-based sequencers for multiple users to deliver multi-sample and multi-experiment sequencing results; and VolTRAX, an USB-powered device, which automates laboratory processes upstream of nanopore sequencing.

Read More

• This Is What To Expect From The S&P 500 Now
• The Two Things You Need To Know About Oracle’s FQ1 Report
• Three Value Stocks For A Volatile Market
• 3 Energy Stocks Nearing Breakouts From Cup-Shaped Patterns
• Do These Dividend Achievers Deserve A Place In Your Portfolio?

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat’s editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider Oxford Nanopore Technologies, you’ll want to hear this.
MarketBeat keeps track of Wall Street’s top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on… and Oxford Nanopore Technologies wasn’t on the list.
While Oxford Nanopore Technologies currently has a “Buy” rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Complete the form below to receive the latest headlines and analysts’ recommendations for your stocks with our free daily email newsletter:
ETF portfolio manager, Dave Gilreath offers a perspective on “dividend achievers” and why these deserve a role in your portfolio
Sign up for MarketBeat All Access to gain access to MarketBeat’s full suite of research tools:
View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.
Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat’s trending stocks report.
Identify stocks that meet your criteria using seven unique stock screeners. See what’s happening in the market right now with MarketBeat’s real-time news feed. Export data to Excel for your own analysis.
MarketBeat All Access subscribers can access stock screeners, the Idea Engine, data export tools, research reports, and other premium tools.
Looking for new stock ideas? Want to see which stocks are moving? View our full suite of financial calendars and market data tables, all for free.
Receive a free world-class investing education from MarketBeat. Learn about financial terms, types of investments, trading strategies and more.
As Featured By:
MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.
Twitter Facebook StockTwits Financial Juice YouTube

© American Consumer News, LLC dba MarketBeat® 2010-2022. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | contact@marketbeat.com | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Privacy Policy | Do Not Sell My Information | RSS Feeds

© 2022 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided ‘as-is’ and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see Barchart’s disclaimer.

source